FMP
Isoray, Inc.
ISR
AMEX
Inactive Equity
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
0.384 USD
0 (0%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Ms. Lori A. Holmes-Woods
sector
Healthcare
industry
Medical - Devices
website
https://isoray.comexchange
AMEX
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
CIK
0000728387
ISIN
US46489V1044
CUSIP
46489V104
Address
350 Hills Street
Phone
509 375 1202
Country
US
Employee
66
IPO Date
May 31, 2002
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
ISR Financial Summary
CIK
0000728387
Exchange
AMEX
Industry
Medical - Devices
Sector
Healthcare
CUSIP
46489V104
ISIN
US46489V1044
Country
US
Price
0.38
Beta
0
Volume Avg.
280.83k
Market Cap
0
Shares
-
52-Week
0.19-0.45
DCF
-0.82
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
0
P/B
-
Website
https://isoray.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ISR News
It looks like there's no news available.
